Pharmaceuticals in Japan

Pharmaceuticals in Japan

Code: ML-OHME4827 | Published: Dec-2015 | Pages: 39 | MarketLine
Price :
$350.00
USD

* Required Fields

$350.00

Details

Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2014 annual average exchange rates.

- The Japanese pharmaceuticals market had total revenues of $85.5bn in 2014, representing a compound annual growth rate (CAGR) of 3.2% between 2010 and 2014.

- In Japan, every citizen is required to participate in the National Health Insurance (NHI) scheme and the majority of health care spending is publically funded through this and other government funds.

- The performance of the market is forecast to accelerate, with an anticipated CAGR of 3.6% for the five-year period 2014 - 2019, which is expected to drive the market to a value of $102.2bn by the end of 2019.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan

Leading company profiles reveal details of key pharmaceuticals market players global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Japan economy

Reasons To Buy
What was the size of the Japan pharmaceuticals market by value in 2014?

What will be the size of the Japan pharmaceuticals market in 2019?

What factors are affecting the strength of competition in the Japan pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in Japans pharmaceuticals market?

Table of Contents

TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Geography segmentation 9
Market share 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 15
New entrants 16
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 21
Daiichi Sankyo Co., Ltd. 21
Mitsubishi Tanabe Pharma Corporation 24
Pfizer Inc. 27
Takeda Pharmaceutical Company Limited 31
Macroeconomic Indicators 34
Country Data 34
Methodology 36
Industry associations 37
Related MarketLine research 37
Appendix 38
About MarketLine 38

List of Tables
Table 1: Japan pharmaceuticals market value: $ billion, 2010-14
Table 2: Japan pharmaceuticals market geography segmentation: $ billion, 2014
Table 3: Japan pharmaceuticals market share: % share, by value, 2014
Table 4: Japan pharmaceuticals market value forecast: $ billion, 2014-19
Table 5: Daiichi Sankyo Co., Ltd.: key facts
Table 6: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 7: Daiichi Sankyo Co., Ltd.: key financials (Yen)
Table 8: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 9: Mitsubishi Tanabe Pharma Corporation: key facts
Table 10: Mitsubishi Tanabe Pharma Corporation: key financials ($)
Table 11: Mitsubishi Tanabe Pharma Corporation: key financials (Yen)
Table 12: Mitsubishi Tanabe Pharma Corporation: key financial ratios
Table 13: Pfizer Inc.: key facts
Table 14: Pfizer Inc.: key financials ($)
Table 15: Pfizer Inc.: key financial ratios
Table 16: Takeda Pharmaceutical Company Limited: key facts
Table 17: Takeda Pharmaceutical Company Limited: key financials ($)
Table 18: Takeda Pharmaceutical Company Limited: key financials (Yen)
Table 19: Takeda Pharmaceutical Company Limited: key financial ratios
Table 20: Japan size of population (million), 2010-14
Table 21: Japan gdp (constant 2005 prices, $ billion), 2010-14
Table 22: Japan gdp (current prices, $ billion), 2010-14
Table 23: Japan inflation, 2010-14
Table 24: Japan consumer price index (absolute), 2010-14
Table 25: Japan exchange rate, 2010-14

List of Figures
Figure 1: Japan pharmaceuticals market value: $ billion, 2010-14
Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2014
Figure 3: Japan pharmaceuticals market share: % share, by value, 2014
Figure 4: Japan pharmaceuticals market value forecast: $ billion, 2014-19
Figure 5: Forces driving competition in the pharmaceuticals market in Japan, 2014
Figure 6: Drivers of buyer power in the pharmaceuticals market in Japan, 2014
Figure 7: Drivers of supplier power in the pharmaceuticals market in Japan, 2014
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2014
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2014
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2014
Figure 11: Daiichi Sankyo Co., Ltd.: revenues and profitability
Figure 12: Daiichi Sankyo Co., Ltd.: assets and liabilities
Figure 13: Mitsubishi Tanabe Pharma Corporation: revenues and profitability
Figure 14: Mitsubishi Tanabe Pharma Corporation: assets and liabilities
Figure 15: Pfizer Inc.: revenues and profitability
Figure 16: Pfizer Inc.: assets and liabilities
Figure 17: Takeda Pharmaceutical Company Limited: revenues and profitability
Figure 18: Takeda Pharmaceutical Company Limited: assets and liabilities
Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Takeda Pharmaceutical Company Limited

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
MarketLine

Our Clients